Table 3.
Clinical outcomes of control and study groups.
| Characteristics | Control group | Study group | P-valueb |
|---|---|---|---|
| N = 537a | N = 537a | ||
| Hospital length of stay | 8.0 (5.0, 15.0) | 12.0 (5.0, 21.0) | <0.001 |
| ICU | 189 (35.2%) | 242 (45.1%) | <0.001 |
| Time of ICU admission | 1.0 (0.0, 3.0) | 1.0 (0.0, 5.0) | 0.026 |
| Days in the ICU | 9.0 (4.0, 19.0) | 7.0 (3.0, 15.0) | 0.100 |
| Mechanical ventilation | 145 (28.0%) | 166 (32.7%) | 0.103 |
| Dialysis | 68 (12.7%) | 85 (15.8%) | 0.138 |
| Sepsis | 78 (14.5%) | 128 (23.8%) | <0.001 |
| Disseminated intravascular coagulation | 2 (0.4%) | 4 (0.7%) | 0.687 |
| Acute cardiac insufficiency | 17 (3.2%) | 24 (4.5%) | 0.265 |
| Acute myocardial infarction | 5 (0.9%) | 10 (1.9%) | 0.194 |
| Myocarditis | 2 (0.4%) | 1 (0.2%) | >0.999 |
| Hemorrhage | 8 (1.5%) | 22 (4.1%) | 0.010 |
| Vascular thrombosis | 19 (3.5%) | 26 (4.8%) | 0.286 |
| Venous thromboembolism | 18 (3.4%) | 24 (4.5%) | 0.345 |
| Arterial thrombosis | 1 (0.2%) | 2 (0.4%) | >0.999 |
| In-hospital mortality | 121 (22.5%) | 192 (35.8%) | <0.001 |
a
n (%); Median (interquartile range);
b
Pearson chi-squared test; Wilcoxon rank sum test; Fisher's exact test. ICU, intensive care unit.